AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21954883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 21954883 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelsemium 5CH and 15CH
Number of subjects: 180
Study 20209421 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper body physical training (UBT) for 12 weeks
Number of subjects: 30
Study 20209421 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 17934422 — intervention group
Group type: EXPERIMENTAL
Intervention: Guidelines for management of patients on oral anticoagulants
Number of subjects: 0
Study 16278591 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic human atrial natriuretic peptide infusion (Group H: n=19)
Number of subjects: 37
Study 16278591 — intervention group
Group type: COMPARATOR
Intervention: Conventional diuretics (furosemide and potassium canrenoate) (Group C: n=18)
Number of subjects: 37
Study 12003988 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 45
Study 12003988 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline/Ciprofloxacin
Number of subjects: 45
Study 10549465 — intervention group
Group type: EXPERIMENTAL
Intervention: Prochlorperazine buccal 6 mg
Number of subjects: 49
Study 10549465 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 7768761 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem, 500 mg q 8 h
Number of subjects: 249
Study 7768761 — intervention group
Group type: COMPARATOR
Intervention: Imipenem/cilastatin, 500 mg/500 mg q 8 h
Number of subjects: 249
Study 7768761 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 249
Study 7768761 — intervention group
Group type: COMPARATOR
Intervention: Imipenem/cilastatin
Number of subjects: 249
Study 2348155 — intervention group
Group type: EXPERIMENTAL
Intervention: Anonymous questionnaires
Number of subjects: 1800
Study 2348155 — intervention group
Group type: COMPARATOR
Intervention: Numbered questionnaires
Number of subjects: 1800
Study 378561 — intervention group
Group type: EXPERIMENTAL
Intervention: Undecylenic acid ointment
Number of subjects: 90
Study 378561 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolnaftate cream
Number of subjects: 90
Study 378561 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 378561 — intervention group
Group type: EXPERIMENTAL
Intervention: Undecylenic acid ointment and Tolnaftate cream
Number of subjects: 90
Study 31687953 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiseptic solution 'Decasan', probiotic 'BioGaia ProDentis', immune modulator 'Imupret'
Number of subjects: 0
Study 31687953 — intervention group
Group type: COMPARATOR
Intervention: Common treatment scheme (control group)
Number of subjects: 0
Study 30170848 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable-polymer sirolimus-eluting stents
Number of subjects: 2119
Study 30170848 — intervention group
Group type: COMPARATOR
Intervention: Durable-polymer everolimus-eluting stents
Number of subjects: 2119
Study 30170848 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 2119
Study 26963147 — intervention group
Group type: EXPERIMENTAL
Intervention: Neodymium: yttrium aluminum garnet (Nd:YAG) laser
Number of subjects: 32
Study 26963147 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional carbon dioxide laser
Number of subjects: 32
Study 26963147 — intervention group
Group type: COMPARATOR
Intervention: Control patch
Number of subjects: 32
Study 24326693 — intervention group
Group type: EXPERIMENTAL
Intervention: Droxidopa (100-600 mg t.i.d.)
Number of subjects: 51
Study 24326693 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 22694796 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week health promotion intervention targeting physical activity and healthy eating
Number of subjects: 324
Study 22694796 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 324
Study 20177025 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow Band Imaging (NBI)
Number of subjects: 320
Study 20177025 — intervention group
Group type: COMPARATOR
Intervention: Conventional White Light Imaging (WLI)
Number of subjects: 320
Study 17974866 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 395
Study 17974866 — intervention group
Group type: COMPARATOR
Intervention: No anti-Alzheimer drugs
Number of subjects: 395
Study 17974866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 395
Study 16280656 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc gluconate glycine lozenges
Number of subjects: 75
Study 16280656 — intervention group
Group type: COMPARATOR
Intervention: Placebo lozenges
Number of subjects: 75
Study 31549625 — intervention group
Group type: EXPERIMENTAL
Intervention: bococizumab 50, 100, or 150 mg
Number of subjects: 218
Study 31549625 — intervention group
Group type: EXPERIMENTAL
Intervention: bococizumab
Number of subjects: 218
Study 31549625 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 218
Study 31549625 — intervention group
Group type: COMPARATOR
Intervention: ezetimibe 10 mg
Number of subjects: 218
Study 11028483 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate 10 mg
Number of subjects: 21
Study 11028483 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 8986929 — intervention group
Group type: EXPERIMENTAL
Intervention: Low salt intake (40 mmol/day)
Number of subjects: 14
Study 8986929 — intervention group
Group type: COMPARATOR
Intervention: High salt intake (170 mmol/day)
Number of subjects: 14
Study 1352328 — intervention group
Group type: EXPERIMENTAL
Intervention: Guarina (guar gum)
Number of subjects: 16
Study 1352328 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 6714903 — intervention group
Group type: EXPERIMENTAL
Intervention: Antacid A (high magnesium content)
Number of subjects: 0
Study 6714903 — intervention group
Group type: EXPERIMENTAL
Intervention: Al-Ca-antacid
Number of subjects: 0
Study 6714903 — intervention group
Group type: EXPERIMENTAL
Intervention: Antacid B (lower magnesium content)
Number of subjects: 0
Study 6714903 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-combination (Al, Mg, Ca)
Number of subjects: 0
Study 6714903 — intervention group
Group type: EXPERIMENTAL
Intervention: Al-Ca-antacid and Al-Mg-Ca-antacid
Number of subjects: 0
Study 31490427 — intervention group
Group type: EXPERIMENTAL
Intervention: RST-SS (Repeated-Sprint Training with Straight Sprints)
Number of subjects: 20
Study 31490427 — intervention group
Group type: EXPERIMENTAL
Intervention: RST-COD (Repeated-Sprint Training with Change of Direction)
Number of subjects: 20
Study 31490427 — intervention group
Group type: COMPARATOR
Intervention: Between-group analysis
Number of subjects: 20
Study 31152977 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg (single oral dose)
Number of subjects: 12
Study 31152977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 29855105 — intervention group
Group type: EXPERIMENTAL
Intervention: 112 interactive text messages delivered over 12 weeks
Number of subjects: 825
Study 29855105 — intervention group
Group type: COMPARATOR
Intervention: 89 texts on general health (control)
Number of subjects: 825
Study 27080318 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised self-management support (discussing SeMaS results and tailored support)
Number of subjects: 644
Study 27080318 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 644
Study 24952281 — intervention group
Group type: EXPERIMENTAL
Intervention: theory-based counseling program led by a community health worker (promotora)
Number of subjects: 600
Study 24952281 — intervention group
Group type: COMPARATOR
Intervention: usual care (control arm)
Number of subjects: 600
Study 22953514 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual microscopy (VM) instruction
Number of subjects: 0
Study 22953514 — intervention group
Group type: COMPARATOR
Intervention: Traditional microscopy (TM) instruction
Number of subjects: 0
Study 21163048 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (n = 39)
Number of subjects: 75
Study 21163048 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat clearance group (n = 36)
Number of subjects: 75
Study 21163048 — intervention group
Group type: COMPARATOR
Intervention: Comparison of N classification
Number of subjects: 75
Study 18486458 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid CRP test (NycoCard)
Number of subjects: 227
Study 18486458 — intervention group
Group type: COMPARATOR
Intervention: Usual laboratory technique for CRP
Number of subjects: 227
Study 16401957 — intervention group
Group type: EXPERIMENTAL
Intervention: Opiate antagonist detoxification under general anesthesia
Number of subjects: 86
Study 16401957 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 86
Study 12662246 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal group interventions (educational or supportive)
Number of subjects: 5
Study 12662246 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured intervention
Number of subjects: 5
Study 12662246 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal therapy
Number of subjects: 5
Study 12662246 — intervention group
Group type: EXPERIMENTAL
Intervention: Unvalidated interventions
Number of subjects: 5
Study 10651701 — intervention group
Group type: EXPERIMENTAL
Intervention: terbinafine 250 mg daily for 12 weeks
Number of subjects: 137
Study 10651701 — intervention group
Group type: COMPARATOR
Intervention: fluconazole 150 mg once weekly for 12 weeks
Number of subjects: 137
Study 10651701 — intervention group
Group type: COMPARATOR
Intervention: fluconazole 150 mg once weekly for 24 weeks
Number of subjects: 137
Study 8885738 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position after epidural analgesia
Number of subjects: 21
Study 8885738 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position with fluid bolus
Number of subjects: 21
Study 8885738 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position after epidural injection
Number of subjects: 21
Study 8885738 — intervention group
Group type: COMPARATOR
Intervention: Lateral position after fluid bolus or epidural
Number of subjects: 21
Study 1519688 — intervention group
Group type: EXPERIMENTAL
Intervention: Orotracheal intubation (group A)
Number of subjects: 68
Study 1519688 — intervention group
Group type: COMPARATOR
Intervention: Nasotracheal intubation (group B)
Number of subjects: 68
Study 31810763 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based tutorial
Number of subjects: 0
Study 31810763 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 30198912 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching exercises for ankle evertor and dorsiflexor muscles, performed 5 days a week for 6 weeks.
Number of subjects: 23
Study 30198912 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified).
Number of subjects: 23
Study 28790547 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg in the morning for 28 days, analgesic (diclofenac 75 mg), high fluid intake
Number of subjects: 104
Study 28790547 — intervention group
Group type: COMPARATOR
Intervention: Control group received analgesic (diclofenac 75 mg), high fluid intake
Number of subjects: 104
Study 24347430 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated radiotherapy with carbogen breathing and nicotinamide (ARCON)
Number of subjects: 0
Study 24347430 — intervention group
Group type: COMPARATOR
Intervention: Accelerated radiotherapy
Number of subjects: 0
Study 23642125 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (12 mg administered in two syringes, 24 hours apart)
Number of subjects: 1449
Study 23642125 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone (11.4 mg administered in two syringes, 24 hours apart)
Number of subjects: 1449
Study 21112155 — intervention group
Group type: EXPERIMENTAL
Intervention: Acamprosate 666 mg three times daily
Number of subjects: 60
Study 21112155 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 19623836 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose antibiotic prophylaxis (cephalexin, gentamycin, cephazolin)
Number of subjects: 0
Study 17520382 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS
Number of subjects: 34
Study 15122056 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD)
Number of subjects: 44
Study 15122056 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD) with CVD
Number of subjects: 44
Study 11239843 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass surgery
Number of subjects: 501
Study 11239843 — intervention group
Group type: COMPARATOR
Intervention: Coronary angioplasty
Number of subjects: 501
Study 9846800 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided tissue regeneration (GTR) with a bioabsorbable membrane, Resolut
Number of subjects: 9
Study 9846800 — intervention group
Group type: COMPARATOR
Intervention: Open debridement procedure (control)
Number of subjects: 9
Study 7848882 — intervention group
Group type: EXPERIMENTAL
Intervention: CMF-based adjuvant chemotherapy
Number of subjects: 2465
Study 7848882 — intervention group
Group type: EXPERIMENTAL
Intervention: Local-regional treatment alone
Number of subjects: 2465
Study 7848882 — intervention group
Group type: EXPERIMENTAL
Intervention: CMF chemotherapy
Number of subjects: 2465
Study 7848882 — intervention group
Group type: EXPERIMENTAL
Intervention: CMF plus Adriamycin (doxorubicin)
Number of subjects: 2465
Study 7848882 — intervention group
Group type: EXPERIMENTAL
Intervention: CMF-based chemotherapy
Number of subjects: 2465
Study 7848882 — intervention group
Group type: EXPERIMENTAL
Intervention: Age > or = 50 years at surgery
Number of subjects: 2465
Study 7848882 — intervention group
Group type: EXPERIMENTAL
Intervention: Age < 50 years at surgery
Number of subjects: 2465
Study 2908133 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketazolam 15 mg
Number of subjects: 92
Study 2908133 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 30998750 — intervention group
Group type: EXPERIMENTAL
Intervention: Yunnan Minority children
Number of subjects: 10037
Study 30998750 — intervention group
Group type: EXPERIMENTAL
Intervention: Yunnan Han children
Number of subjects: 10037
Study 30998750 — intervention group
Group type: COMPARATOR
Intervention: Guangdong Han children
Number of subjects: 10037
Study 27817180 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Administered Stress Management Training (SSMT)
Number of subjects: 219
Study 27817180 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UCO)
Number of subjects: 219
Study 27817180 — intervention group
Group type: EXPERIMENTAL
Intervention: SSMT with psychotropic agent
Number of subjects: 219
Study 25880278 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain cigarette packs
Number of subjects: 128
Study 25880278 — intervention group
Group type: COMPARATOR
Intervention: Usual UK brand
Number of subjects: 128
Study 24348500 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial support intervention consisting of three components over 12 months
Number of subjects: 230
Study 24348500 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 230
Study 21150199 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical methylprednisolone applied to the round window during cochlear implantation
Number of subjects: 43
Study 21150199 — intervention group
Group type: COMPARATOR
Intervention: Control group (no steroid treatment)
Number of subjects: 43
Study 21150199 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical methylprednisolone
Number of subjects: 43
Study 19730280 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonazepam 4 mg
Number of subjects: 23
Study 17089357 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-21 + low-dose IL-2
Number of subjects: 5
Study 17089357 — intervention group
Group type: COMPARATOR
Intervention: IL-15 + low-dose IL-2
Number of subjects: 5
Study 15361080 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole (20 mg b.i.d.), ofloxacin (400 mg b.i.d.), amoxicillin (1000 mg b.i.d.) for 7 days
Number of subjects: 76
Study 15361080 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole (20 mg b.i.d.), ofloxacin (400 mg b.i.d.), amoxicillin (1000 mg b.i.d.) for 14 days
Number of subjects: 76
Study 11393446 — intervention group
Group type: EXPERIMENTAL
Intervention: High self-monitors using impression-management tactics (ingratiation, self-promotion, exemplification)
Number of subjects: 339
Study 11393446 — intervention group
Group type: COMPARATOR
Intervention: Low self-monitors using impression-management tactics
Number of subjects: 339
Study 9327336 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal immunization
Number of subjects: 16
Study 9327336 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular immunization
Number of subjects: 16
Study 8424302 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (9 micrograms.kg‐1 x h‐1) during CPB
Number of subjects: 16
Study 8424302 — intervention group
Group type: COMPARATOR
Intervention: Control group (no calcium channel blocker)
Number of subjects: 16
Study 3316308 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 24
Study 3316308 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 31217028 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement package (SUSTAIN) including training, mentoring, feedback, and introduction of portable fetal heart monitors (Moyo®) and neonatal heart rate monitors (Neobeat®).
Number of subjects: 8
Study 31217028 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement training and mentoring for health workers on standard basic neonatal resuscitation and essential newborn care.
Number of subjects: 8
Study 28638025 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy exercises on the 3rd, 5th, 7th and 9th days of rehabilitation
Number of subjects: 45
Study 28638025 — intervention group
Group type: COMPARATOR
Intervention: Basic set of physical exercises (control group)
Number of subjects: 45
Study 26244306 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir gel
Number of subjects: 422
Study 26244306 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 422
Study 26244306 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir gel (with vaginal concentrations of 10,000 ng/mL or more)
Number of subjects: 422
Study 26244306 — intervention group
Group type: COMPARATOR
Intervention: No detectable vaginal tenofovir
Number of subjects: 422
Study 23578015 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2 mg/kg/day atomoxetine for 20 weeks
Number of subjects: 88
Study 21320923 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir plus ritonavir
Number of subjects: 928
Study 21320923 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz
Number of subjects: 928
Study 18812431 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortical stimulation (CS) combined with rehabilitation for 6 weeks, delivered during therapy.
Number of subjects: 174
Study 18812431 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving the same therapy without device implantation or stimulation.
Number of subjects: 174
Study 16904298 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotic drugs (haloperidol, risperidone, olanzapine, quetiapine)
Number of subjects: 305
Study 16904298 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305
Study 15051771 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (RT)
Number of subjects: 99
Study 12215593 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase (SK) treatment
Number of subjects: 270
Study 12215593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study 9578190 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral theophylline 10 mg kg(‐1) day(‐1)
Number of subjects: 18
Study 9578190 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 7713093 — intervention group
Group type: EXPERIMENTAL
Intervention: Coumarin anticoagulation (Group I)
Number of subjects: 200
Study 7713093 — intervention group
Group type: COMPARATOR
Intervention: No oral anticoagulation (Group II)
Number of subjects: 200
Study 1369851 — intervention group
Group type: EXPERIMENTAL
Intervention: McIntosh hemiarthroplasty of the knee
Number of subjects: 35
Study 360120 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin (8-hour, 3-dose regimen)
Number of subjects: 97
Study 360120 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 360120 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 97
Study 360120 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 97
Study 31159776 — intervention group
Group type: EXPERIMENTAL
Intervention: S&G exercise intervention (combining supervised exercise with gamification and social incentives via WeChat)
Number of subjects: 420
Study 31159776 — intervention group
Group type: EXPERIMENTAL
Intervention: S&G exercise intervention
Number of subjects: 420
Study 31159776 — intervention group
Group type: COMPARATOR
Intervention: Supervised exercise (SE)
Number of subjects: 420
Study 28296334 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 25 mg single dose
Number of subjects: 24
Study 25220215 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg methylphenidate
Number of subjects: 50
Study 25220215 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 23298335 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary phylloquinone intake (upper tertile)
Number of subjects: 510
Study 23298335 — intervention group
Group type: COMPARATOR
Intervention: Dietary phylloquinone intake (lowest tertile)
Number of subjects: 510
Study 21672543 — intervention group
Group type: EXPERIMENTAL
Intervention: Cues to low cortisol in male faces
Number of subjects: 0
Study 21672543 — intervention group
Group type: COMPARATOR
Intervention: High testosterone levels
Number of subjects: 0
Study 18049097 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc-DTPA aerosol inhalation scintigraphy
Number of subjects: 28
Study 18049097 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary function tests (PFT)
Number of subjects: 28